Insmed Incorporated (0JAV)
LSE
Closed
Oct 7, 2026
Day's Range
102.0052 wk Range
91.59Overview - 0JAV - Insmed Incorporated
Key Statistics
Valuation
Enterprise Value
23.41B
P/E (Trailing)
‪2.40‬
PEG Ratio
‪0.08‬
Price / Sales (TTM)
‪0.0047‬
Price / Book
‪31.45‬
EV / EBITDA
‪-29.45‬
Profitability
Gross Margin
‪34.67%‬
Profit Margin
‪-76.94%‬
Operating Margin
‪-23.80%‬
Return on Assets
‪-22.16%‬
Return on Equity
‪-87.21%‬
Ownership
Shares Outstanding
77.09M
Float
216.93M
Held by Insiders
‪0.50%‬
Held by Institutions
‪104.98%‬
Price stats
Beta
‪0.81‬
50-Day Avg
‪28.37‬
200-Day Avg
‪24.95‬
Dividends
Frequency
Semi-Annual
Market Cap - 0JAV - Insmed Incorporated
Peers - 0JAV - Insmed Incorporated
Peer Comparison
Compared with companies in Biotechnology listed on LSE.
Profile Summary - 0JAV - Insmed Incorporated
About
Insmed Incorporated is a global biopharmaceutical company that develops and commercializes therapies for patients with serious and rare diseases. Its current portfolio includes an approved treatment for Mycobacterium avium complex lung disease, along with clinical-stage programs focused on pulmonary and inflammatory…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
